WBUR Covers Convergence of AI and Precision Medicine

June 8, 2018 – WBUR, the largest of the three Boston NPR-affiliates, produced a series on the biotech boom in Boston this week, coinciding with the 2018 BIO conference that took place at the Boston Convention Center from June 4-7. Today, reporter Karen Weintraub dove into the rapidly converging fields of AI and precision medicine […]

Roche Precision Medicine Article Features Iya Khalil

Dr. Iya Khalil, GNS chief commercial officer and co-founder, gave her perspectives on the application of machine learning to clinical trials in “Partnering in the Digital Era“, an article published by Roche this week. The precision medicine piece focuses on how collaborations between healthcare and technology companies are driving the future of healthcare and features […]

GNS Healthcare Licenses REFS™ Causal Machine Learning and Simulation Platform to Alexion to Accelerate Discovery of New Treatments for Rare Diseases

CAMBRIDGE, Mass. – August 10, 2017– GNS Healthcare (GNS), a leading precision medicine company that applies causal machine learning technology to large and diverse data sets to better match drugs and other health interventions to individual patients, today announced that it has entered into a license arrangement with Alexion for the rights to operate its REFS™ […]

Sema4 and GNS Healthcare Announce Collaboration Using REFS™ Causal Machine Learning and Simulation AI Platform

Working Towards New Therapies for Cardiovascular Disease Stamford, Conn. and Cambridge, Mass. – June 27, 2017– Sema4, an interdisciplinary health information company with expertise in collecting diverse data, building computational models of disease and unlocking solutions to disease, today announced it is leveraging GNS Healthcare’s (GNS), REFS™ (Reverse Engineering and Forward Simulation) causal machine learning […]

GNS Healthcare Announces Collaboration to Power Cancer Drug Development with REFS™ Causal Machine Learning and Simulation AI Platform

CAMBRIDGE, Mass.– June 19, 2017 – GNS Healthcare (GNS), a leading precision medicine company, today announced a collaboration with Genentech, a member of the Roche Group to leverage GNS REFS™ (Reverse Engineering and Forward Simulation) causal machine learning and simulation platform to power the development of novel cancer therapies. The GNS technology turns large and diverse […]

GNS Healthcare and Regence Blue Cross Blue Shield Co-Present Machine Learning Enhanced Advanced Illness Program at Annual Blues National Summit

CAMBRIDGE, Mass. – May 9, 2017– GNS Healthcare (GNS), a leading precision medicine company that applies causal machine learning technology to large and diverse data sets to better match health interventions to individual patients to improve health outcomes and lower the total cost of care, will present its Advanced Illness solution, in collaboration with Regence Blue […]

GNS Taps Nationally Regarded Epidemiologist to Put Discoveries From Causal Machine Learning and Simulation Platform in ‘Clinical Context’

Veteran Healthcare Leader Julie Slezak Appointed to Executive Vice President of Clinical Analytics CAMBRIDGE, Mass. – April 4, 2017 – Leading precision medicine company GNS Healthcare (GNS) today announced that nationally regarded epidemiologist and biostatistician Julie Slezak has been named to the newly created position Executive Vice President of Clinical Analytics. Slezak, who previously headed […]

Xconomy Features Celgene-GNS REFS License, Investment Deal

Celgene has made a second investment in GNS Healthcare and is tapping into the firm’s data analytics software to boost Celgene’s drug discovery and development efforts. Read the full story here.

Gov. Charlie Baker Appoints GNS Healthcare CEO Colin Hill to Newly Formed Massachusetts Digital Health Council

Hill Joins Group of State’s Leading Experts to Promote, Accelerate Digital Health Innovation in Massachusetts BOSTON, Mass. – November 22, 2016 – Today Colin Hill, the Chairman, CEO and co-founder of leading precision medicine company GNS Healthcare (GNS), was appointed by Massachusetts Gov. Charlie Baker to the newly formed Massachusetts Digital Health Council. The Council, […]

GNS REFS™ Causal Machine Learning Platform Featured in GEN (Genetic Engineering & Biotechnology News)

GNS Healthcare’s causal machine learning platform REFS (Reverse Engineering , Forward Simulation) turns healthcare data into actionable insights to guide precision medicine and scientific discovery. “We reverse engineer causal models from healthcare data,” explains Diane Wuest, Ph.D., associate director, precision medicine initiatives, GNS Healthcare. “Once these models are built, they can be forward simulated and queried […]